How much does a box of eflornithine tablets cost the latest?
Eflornithine tablets(eflornithine) is a drug with specific pharmacological effects, mainly used to reduce the risk of recurrence in patients with high-risk neuroblastoma (HRNB). This drug plays a key role in the treatment process by inhibiting the activity of ornithine decarboxylase, affecting cell proliferation and growth. Especially for patients who have already received multiple treatments, including anti-GD2 immunotherapy, and have shown partial responses, eflornithine can further reduce the likelihood of tumor recurrence.

Although eflornithine is approved in some international markets, it is not yet available in China. Therefore, domestic patients still have unclear information about the price and medical insurance coverage of eflornithine. According to overseas market data, the original drug specification of eflornithine is 192mg, each box contains 100 tablets, and the price is approximately more than 10,000 US dollars. This high price places a financial burden on many patients, affecting their ability to receive treatment.
Due to the special application and relatively small market supply of eflornithine, its clinical use needs to be carried out under the guidance of professional doctors. For patients with high-risk neuroblastoma, the use of eflornithine is often decided after a comprehensive assessment of the patient's condition. Doctors need to take into account the patient's specific condition, previous treatment response and possible side effects. In addition, the production of eflornithine is strictly regulated, resulting in certain restrictions on its global supply, which may also lead to drug shortages and thus affect the treatment process of patients.
Overall, eflornithine tablets demonstrate unique potential in the field of cancer treatment, particularly in the management of high-risk neuroblastoma. However, the availability of this drug is limited due to its not yet being launched in the Chinese market and its high international price.
Reference materials:https://www.drugs.com/mtm/eflornithine.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)